Stent Restenosis    Macrophage migration inhibitory factor in cardiovascular disease Circulation (2008) 117; 1594-602 A. Zernecke, J. Bernhagen and C. Weber Rates of stent thrombosis in bare-metal versus drug-eluting stents (from a large Australian multicenter registry) Am J Cardiol (2008) 101; 1716-22 B. P. Yan, S. J. Duffy, D. J. Clark, J. Lefkovits, R. Warren, R. Gurvitch, R. Lew, M. Sebastian, A. Brennan, N. Andrianopoulos, C. M. Reid and A. E. Ajani Long-term clinical outcomes after sirolimus-eluting stent implantation for treatment of restenosis within bare-metal versus drug-eluting stents Catheter Cardiovasc Interv (2008) 71; 594-8 C. Whan Lee, S. H. Kim, J. Suh, D. W. Park, S. H. Lee, Y. H. Kim, M. K. Hong, J. J. Kim, S. W. Park and S. J. Park Outcome differences with the use of drug-eluting stents for the treatment of in-stent restenosis of bare-metal stents versus drug-eluting stents Am J Cardiol (2009) 103; 491-5 D. H. Steinberg, M. A. Gaglia, Jr., T. L. Pinto Slottow, P. Roy, L. Bonello, A. De Labriolle, G. Lemesle, R. Torguson, K. Kineshige, Z. Xue, W. O. Suddath, K. M. Kent, L. F. Satler, A. D. Pichard, J. Lindsay and R. Waksman Angiographic patterns of drug-eluting stent restenosis and one-year outcomes after treatment with repeated percutaneous coronary intervention Am J Cardiol (2008) 102; 311-5 E. Solinas, G. Dangas, A. J. Kirtane, A. J. Lansky, T. Franklin-Bond, P. Boland, G. Syros, Y. H. Kim, A. Gupta, G. Mintz, M. Fahy, M. Collins, S. Kodali, G. W. Stone, J. W. Moses, M. B. Leon and R. Mehran Stent fracture, an incidental finding or a significant marker of clinical in-stent restenosis Catheter Cardiovasc Interv (2008) 71; 614-8 F. Shaikh, R. Maddikunta, M. Djelmami-Hani, J. Solis, S. Allaqaband and T. Bajwa Commentary on drug-eluting stents: NICE technology appraisal guidance Heart (2008) 94; 1650-2 J. Richardson, A. Stevens, D. Barnett and C. Longson Observations and outcomes of definite and probable drug-eluting stent thrombosis seen at a single hospital in a four-year period Am J Cardiol (2008) 102; 298-303 T. L. Pinto Slottow, D. H. Steinberg, P. K. Roy, A. N. Buch, T. Okabe, Z. Xue, K. Kaneshige, R. Torguson, J. Lindsay, A. D. Pichard, L. F. Satler, W. O. Suddath, K. M. Kent and R. Waksman Noninvasive assessment of coronary in-stent restenosis by dual-source computed tomography Am J Cardiol (2009) 103; 812-7 T. Pflederer, M. Marwan, A. Renz, S. Bachmann, D. Ropers, A. Kuettner, K. Anders, F. Bamberg, W. G. Daniel and S. Achenbach Commentary on drug-eluting stents: to use or not to use--that is the question! Heart (2008) 94; 1648-50 M. E. Pfisterer Optimal treatment for in-stent restenosis after BMS--DES, coated balloon, or scalpel Eur Heart J (2008) 29; 1595-6 D. Mukherjee Randomized trial of three rapamycin-eluting stents with different coating strategies for the reduction of coronary restenosis Eur Heart J (2008) 29; 1975-82 J. Mehilli, R. A. Byrne, A. Wieczorek, R. Iijima, S. Schulz, O. Bruskina, J. Pache, R. Wessely, A. Schomig and A. Kastrati Usefulness of 64-detector row computed tomography for evaluation of intracoronary stents in symptomatic patients with suspected in-stent restenosis Am J Cardiol (2008) 101; 1567-73 N. Manghat, R. Van Lingen, P. Hewson, F. Syed, N. Kakani, I. Cox, C. Roobottom and G. Morgan-Hughes Comparison of the sirolimus-eluting versus paclitaxel-eluting coronary stent in patients with diabetes mellitus: the diabetes and drug-eluting stent (DiabeDES) randomized angiography trial Am J Cardiol (2009) 103; 345-9 M. Maeng, L. O. Jensen, A. M. Galloe, P. Thayssen, E. H. Christiansen, K. N. Hansen, S. Helqvist, H. E. Botker, J. F. Lassen and L. Thuesen An integrated TAXUS IV, V, and VI intravascular ultrasound analysis of the predictors of edge restenosis after bare metal or paclitaxel-eluting stents Am J Cardiol (2009) 103; 501-6 J. Liu, A. Maehara, G. S. Mintz, N. J. Weissman, A. Yu, H. Wang, L. Mandinov, J. J. Popma, S. G. Ellis, E. Grube, K. D. Dawkins and G. W. Stone Drug-eluting stenting followed by cilostazol treatment reduces late restenosis in patients with diabetes mellitus the DECLARE-DIABETES Trial (A Randomized Comparison of Triple Antiplatelet Therapy with Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Diabetic Patients) J Am Coll Cardiol (2008) 51; 1181-7 S. W. Lee, S. W. Park, Y. H. Kim, S. C. Yun, D. W. Park, C. W. Lee, M. K. Hong, H. S. Kim, J. K. Ko, J. H. Park, J. H. Lee, S. W. Choi, I. W. Seong, Y. H. Cho, N. H. Lee, J. H. Kim, K. J. Chun and S. J. Park Stent strut fracture-induced restenosis in the right coronary artery: detection by MDCT Heart (2008) 94; 221 S. U. Kwon, J. H. Doh, J. Namgung and S. Y. Lee A novel bioresorbable polymer paclitaxel-eluting stent for the treatment of single and multivessel coronary disease: primary results of the COSTAR (Cobalt Chromium Stent With Antiproliferative for Restenosis) II study J Am Coll Cardiol (2008) 51; 1543-52 M. W. Krucoff, D. J. Kereiakes, J. L. Petersen, R. Mehran, V. Hasselblad, A. J. Lansky, P. J. Fitzgerald, J. Garg, M. A. Turco, C. A. Simonton, 3rd, S. Verheye, C. L. Dubois, R. Gammon, W. B. Batchelor, C. D. O'Shaughnessy, J. B. Hermiller, Jr., J. Schofer, M. Buchbinder and W. Wijns Clinical presentation of patients with late target lesion revascularization Catheter Cardiovasc Interv (2008) 72; 749 H. Kaneda Usefulness of 64-detector computed tomographic angiography for diagnosing in-stent restenosis in native coronary arteries Am J Cardiol (2008) 101; 820-4 H. S. Hecht, M. Zaric, V. Jelnin, L. Lubarsky, M. Prakash and G. Roubin Late stent malapposition risk is higher after drug-eluting stent compared with bare-metal stent implantation and associates with late stent thrombosis Eur Heart J (2009) A. K. Hassan, S. C. Bergheanu, T. Stijnen, B. L. van der Hoeven, J. D. Snoep, J. W. Plevier, M. J. Schalij and J. W. Jukema Late drug-eluting stent thrombosis of unprotected left main coronary artery lesions--sometimes possible but rarely definite or probable Eur Heart J (2008) H. Hamdalla and D. J. Moliterno Comparative safety and efficacy of a sirolimus-eluting versus paclitaxel-eluting stent: a meta-analysis Am Heart J (2008) 155; 630-9 H. S. Gurm, T. Boyden and K. B. Welch Balancing the risks of restenosis and stent thrombosis in bare-metal versus drug-eluting stents: results of a decision analytic model J Am Coll Cardiol (2008) 51; 1844-53 P. Garg, D. J. Cohen, T. Gaziano and L. Mauri Contribution of organized thrombus to in-stent restenosis after sirolimus-eluting stent implantation: optical coherence tomography findings Eur Heart J (2008) 29; 1385 K. Fujii, M. Masutani and M. Ohyanagi Predictive factors for in-stent late loss and coronary lesion progression in patients with type 2 diabetes mellitus randomized to rosiglitazone or placebo Am Heart J (2009) 157; 383 e1-8 A. V. Finn, J. S. Oh, M. Hendricks, M. Daher, E. Cagliero, R. M. Byrne, J. Nadelson, J. Crimins, A. Kastrati, A. Schomig, O. Bruskina, I. Palacios, M. C. John and H. K. Gold Four-year clinical follow-up of the rapamycin-eluting stent evaluated at Rotterdam Cardiology Hospital registry J Am J Cardiol (2008) 101; 1105-11 . Daemen, N. Kukreja, P. H. van Twisk, Y. Onuma, P. P. de Jaegere, R. van Domburg and P. W. Serruys Comparison of outcomes of drug-eluting stents versus bare-metal stents in nonostial proximal left anterior descending coronary arteries Am J Cardiol (2009) 103; 496-500 L. Bonello, A. De Labriolle, G. Lemesle, P. Roy, D. H. Steinberg, T. L. Slottow, Z. Xue, R. Torguson, K. Kaneshige, W. O. Suddath, L. F. Satler, K. M. Kent, J. Lindsay, A. D. Pichard and R. Waksman Tailored clopidogrel loading dose according to platelet reactivity monitoring to prevent acute and subacute stent thrombosis Am J Cardiol (2009) 103; 5-10 L. Bonello, L. Camoin-Jau, S. Armero, O. Com, S. Arques, C. Burignat-Bonello, M. P. Giacomoni, R. Bonello, F. Collet, P. Rossi, P. Barragan, F. Dignat-George and F. Paganelli Treatment of drug-eluting stent restenosis: An emerging challenge Catheter Cardiovasc Interv (2008) A. Aminian, T. Kabir and E. Eeckhout Sirolimus-eluting stents versus bare-metal stents in patients with in-stent restenosis: results of a pooled analysis of two randomized studies Catheter Cardiovasc Interv (2008) 72; 459-67 F. Alfonso, M. J. Perez-Vizcayno, R. Hernandez, C. Fernandez, J. Escaned, C. Banuelos, A. Bethencourt, J. R. Lopez-Minguez, J. Angel, A. Cequier, M. Sabate, C. Moris, J. Zueco and R. Seabra-Gomes Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study J Am Coll Cardiol (2008) 52; 1621-7 F. Alfonso, M. J. Perez-Vizcayno, R. Hernandez, A. Bethencourt, V. Marti, J. R. Lopez-Minguez, J. Angel, A. Iniguez, C. Moris, A. Cequier, M. Sabate, J. Escaned, P. Jimenez-Quevedo, C. Banuelos, A. Suarez and C. Macaya